![Erik Emerson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erik Emerson
Corporate Officer/Principal chez
ODYSSEY HEALTH, INC.
Fortune : 1 M $ au 31/05/2026
Profil
Erik Emerson was the founder of Symplmed Pharmaceuticals LLC, founded in 2013, where the title held was President & Chief Executive Officer from 2013 to 2018.
Current jobs include Chief Commercial Officer at Odyssey Health, Inc., and President at Apimeds Pharmaceuticals US, Inc. starting in 2025.
Former jobs include Director at Adhera Therapeutics, Inc. in 2019, Marketing Director at Gilead Sciences, Inc. from 2007 to 2010, Senior Director-Commercial Development at XOMA Royalty Corp.
from 2010 to 2013, and Chief Commercial Officer at Mezzion Pharmaceuticals, Inc. from 2017 to 2020.
Education includes undergraduate studies at the University of Oregon.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
4,97 % | 15/10/2025 | 750 000 ( 4,97 % ) | 1 M $ | 31/05/2026 |
Postes actifs de Erik Emerson
| Sociétés | Poste | Début |
|---|---|---|
| ODYSSEY HEALTH, INC. | Corporate Officer/Principal | - |
Anciens postes connus de Erik Emerson
| Sociétés | Poste | Fin |
|---|---|---|
Mezzion Pharmaceuticals, Inc.
 Mezzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug manufacturing company | Corporate Officer/Principal | 01/01/2020 |
| ADHERA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 19/12/2019 |
Symplmed Pharmaceuticals LLC
 Symplmed Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Général | 01/05/2018 |
| XOMA ROYALTY CORPORATION | Corporate Officer/Principal | 01/07/2013 |
| GILEAD SCIENCES, INC. | Sales & Marketing | 01/05/2010 |
Formation de Erik Emerson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
46
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
XOMA Royalty Corp.
 XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Odyssey Health, Inc.
 Odyssey Health, Inc. Medical SpecialtiesHealth Technology Develops heart monitoring and screening devices | Health Technology |
University of Oregon
 University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adhera Therapeutics, Inc.
 Adhera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes hypertensive drugs | Health Technology |
Symplmed Pharmaceuticals LLC
Symplmed Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Mezzion Pharmaceuticals, Inc.
Mezzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug manufacturing company | Health Technology |
Choisissez Zonebourse 
